ScholarX: HAHN, JOO YONG

Detailed Information

HAHN, JOO YONG (한주용)

Medicine (Medicine)

Research Area

Tel 02-3410-3419
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

percutaneous coronary intervention:60||Percutaneous coronary intervention:47||prognosis:31||coronary artery disease:21||fractional flow reserve:21||Acute myocardial infarction:19||Cardiogenic shock:18||Prognosis:17||Myocardial infarction:17||Coronary artery disease:16||myocardial infarction:16||drugeluting stent:11||Extracorporeal membrane oxygenation:10||coronary flow reserve:10||Chronic total occlusion:10||index of microcirculatory resistance:10||drugeluting stents:9||bifurcation:9||cardiogenic shock:9||Drugeluting stent:9||acute myocardial infarction:9||Outcomes:8||acute coronary syndrome:8||STsegment elevation myocardial infarction:8||quantitative flow ratio:7||Mortality:6||Revascularization:6||intravascular ultrasound:6||Percutaneous Coronary Intervention:6||outcomes:6||Fractional flow reserve:6||mortality:5||multivessel disease:5||Cardiac magnetic resonance imaging:5||instantaneous wavefree ratio:5||Bifurcation:5||Magnetic resonance imaging:5||ischemia:5||Statin:5||Dual antiplatelet therapy:5||angiography:5||Clopidogrel:4||angioplasty:4||Drugeluting stents:4||STelevation myocardial infarction:4||revascularization:4||Intravascular imaging:4||Intravascular ultrasound:4||coronary angiography:4||Vasospastic angina:4||clinical outcome:4||Acute coronary syndrome:4||complete revascularization:4||Heart failure:4||Myocardial Infarction:3||myocardial ischemia:3||Side branch:3||outcome:3||Medical therapy:3||Aspirin:3||Echocardiography:3||Coronary artery bypass grafting:3||Angioplasty:3||Index of microcirculatory resistance:3||coronary bifurcation lesion:3||Optical coherence tomography:3||Multivessel disease:3||intravascular imaging:3||Cardiopulmonary resuscitation:3||Bifurcation lesion:3||coronary microvascular dysfunction:3||microcirculation:3||registries:3||chronic total occlusion:3||heart failure:3||coronary CT angiography:3||drugeluting stent(s):3||Bifurcation stenting:2||heart failure with preserved ejection fraction:2||heart transplantation:2||adjunctive pharmacotherapy:2||instent restenosis:2||incidence:2||Coronary Artery Disease:2||Diabetes:2||Diastolic dysfunction:2||Diastolic pressure ratio:2||Antiplatelet therapy:2||Medina classification:2||left ventricular ejection fraction:2||Resting fullcycle ratio:2||Bleeding:2||Microvascular obstruction:2||Risk assessment:2||Coronary artery bypass graft:2||Coronary artery bypass graft surgery:2||microvascular resistance reserve:2||multiple vessel disease:2||chronic coronary total occlusion:2||chronic kidney disease:2||2stent strategy:2||Myocardial ischemia:2||clinical outcomes:2||optical coherence tomography:2||DrugEluting Stents:2||clopidogrel:2||Natural mild hypothermia:2||complex lesion:2||Nitrates:2||Stenosis:2||Obesity:2||coronary artery bypass grafting:2||Thrombectomy:2||Dual Antiplatelet Therapy:2||Outcome:2||coronary disease:2||coronary intervention:2||Bifurcation lesions:2||Chronic total coronary occlusion:2||Instent restenosis:2||Instantaneous wavefree ratio:2||Intensive care unit:2||diabetes:2||Uric Acid:2||statin:2||drugcoated balloon:2||stent:2||stent technique:2||stents:2||drugeluting balloon:2||thrombosis:2||Vasospastic Angina:2||extracorporeal membrane oxygenation:2||Ischemic territory:2||fractional flow reserve, myocardial:2||fractional myocardial mass:2||Left Ventricular Systolic Dysfunction:2||Coronary thrombosis:2||vasospastic angina:2||Extracorporeal circulation:2||Medical treatment:1||Medication therapy:1||Metaanalysis:1||Microvascular angina:1||Monotherapy:1||Multidisciplinary team:1||Murray&apos:1||Myocardial injury:1||Myocardial ischemic burden:1||Nicorandil:1||Nitrate:1||No reflow:1||NonSTelevation myocardial infarction:1||Nurse staffing:1||Optimal medical therapy:1||Optimal medical treatment:1||P2Y<:1||P2Y(12) inhibitors:1||P2Y12 Inhibitor:1||PCI:1||PCI  Percutaneous Coronary Intervention:1||PREdiction of DELIRium:1||Pathology:1||Percutaneous cardiopulmonary support:1||Percutaneous closure:1||Percutaneous coronary intervention (PCI):1||Percutaneous transluminal coronary angioplasty:1||Periprocedural MI:1||Peripheral Artery Disease:1||Pharmacotherapy:1||PivotTR system:1||Platelet aggregation inhibitors:1||Polymers:1||Positron emission tomography:1||Predictor:1||Primary percutaneous coronary intervention:1||Pro cedural optimization:1||Proximal or middle left anterior descending artery:1||Pulse pressure:1||Qualityadjusted life year:1||Quantitative coronary angiography:1||Quantitative flow ratio:1||Randomized clinical trial:1||Realworld data:1||Reciprocal change of electrocardiogram:1||Relative survival:1||Renal function:1||Residual stenosis:1||Restenosis:1||Resuscitation:1||Reva:1||Risk Risk stratifcation:1||STelevation myocardial infarc:1||STsegmentelevation myocardial infarction:1||STEMI:1||Safety:1||Secondgeneration drugeluting stent:1||Secondary prevention:1||Serum lactate:1||Sex difference:1||Shock index:1||Side branch occlusion:1||Side branch predilation:1||Silent myocardial ischemia:1||Stelevation myocardial infarction:1||Stable ischaemic heart disease:1||Stent thrombosis:1||Stenting:1||Stents:1||Stressinduced cardiomyopathy · Gender difference · Clinical characteristics · Preceding stress events · Clinical outcomes.:1||T:1||Therapy:1||Thrombosis:1||Timing:1||Tobacco cessation:1||Transfusion:1||Transmural necrosis:1||Transradial approach:1||Treatment outcome:1||Trend:1||Tricuspid regurgitation:1||Triple ruleout computed tomography:1||Troponin:1||TwoStent:1||Ultrasonic:1||Ultrasonography, interventional:1||Underexpansion:1||Variant angina:1||Vasoactive Inotropic Score:1||Vasoactive inotrope score:1||Vasoactive inotropic score:1||Vasospasm:1||Venoarterialextracorporeal membrane oxygenation:1||Ventricular remodeling:1||Visceral adiposity:1||Wall shear stress:1||White blood cell:1||Women:1||Zotarolimuseluting stents:1||abundant collateral:1||acute coronary syndrome(s):1||advanced cardiac life support:1||anatomicalphysiological discordance:1||angiographybased physiology:1||angiographyderived fractional flow reserve:1||antiplatelet therapy:1||aspirin:1||betablocker:1||betablockers:1||bifurcation lesion:1||bifurcation lesions:1||bifurcations:1||biocompatible coating:1||body mass index:1||cardiac MRI:1||cardiac diastolic dysfunction:1||cardiac intensive care unit:1||cardiac intensivist:1||cardiac magnetic resonance imaging:1||cardiology:1||cardiopulmonary arrest:1||cardiopulmonary bypass:1||cardiopulmonary resuscitation:1||cardiovascular events:1||chronic coronary syndrome:1||chronic renal insufficiency:1||cilostazol:1||clinical:1||clinical research:1||clinical trial:1||collateral circulation:1||complex PCI:1||complex percutaneous coronary intervention:1||complications:1||computational fluid dynamics:1||computed tomographic angiography:1||computed tomography:1||conditional survival:1||contrast media:1||coronary artery:1||coronary artery bypass graft:1||coronary artery physiology:1||coronary atherosclerotic disease:1||coronary bifurcation lesions:1||coronary col:1||coronary microcirculation:1||coronary occlusion:1||coronary spasm:1||coronary vasospasm:1||coronary vessels:1||critical care:1||culprit:1||cumulative burden:1||de novo:1||delirium prediction:1||diabetes mellitus:1||diagnostic agreement:1||diastolic pressure ratio:1||diastolic pressureratio:1||disease patterns:1||door‐to‐balloon time:1||dopamine:1||ePTFE:1||echocardiography:1||endoscopic ultrasoundguided fine needle aspiration:1||exercise test:1||extracorporeal circulation:1||followup studies:1||frailty:1||functional angiography:1||gender outcomes/studies:1||graft rejection:1||health care:1||health care sector:1||highdose statin:1||humans:1||imaging:1||immediate complete revascularization:1||implantable medical device:1||inflammation:1||inhibitors:1||instantaneous wave‐free ratio:1||intensive care unit:1||intermediate coronary stenosis:1||interventional:1||intracoronary morphine:1||intravascular ul:1||intravascular ultrasonography:1||ischemic heart disease:1||kissing ballooning:1||left main coronary artery:1||left ventricular enddiastolic pressure:1||let heart catheterization:1||local severity:1||longterm clinical outcomes:1||low‐density lipoprotein cholesterol:1||lung neoplasm:1||magnetic resonance imaging:1||mechanical circulatory support:1||medication:1||metaanalysis:1||microvascular dysfunction:1||microvascular function:1||miscellaneous coronary:1||multidetector computed tomography:1||neoplasm staging:1||nitinol:1||nonSTelevation myocardial infarction:1||nonSTEMI:1||nonleft main coronary artery disease:1||norepinephrine:1||obesity:1||operator experience:1||optical coherence:1||other technique:1||outcome assessment:1||paclitaxelcoated balloon:1||patient reported outcome measures:1||patients:1||percutaneous cardiopulmonary support:1||percutaneous coronary interventions:1||percutaneous t:1||periprocedural MI:1||peristrut low inten:1||perioperative care:1||pharmacology:1||physiology:1||platelets:1||polyurethane:1||postinfarct fever:1||prediction model:1||prevention:1||probability:1||provisional 1stent strategy:1||quality of life:1||randomized:1||randomized controlled trial:1||realworld data:1||rejection:1||remission:1||renal failure:1||renal insufficiency:1||reperfusion injury:1||residual SYNTAX score:1||restenosis:1||resting fullcycle ratio:1||risk stratification:1||s law:1||sarcopenia:1||sarpogrelate:1||second generation:1||secondgeneration drugeluting stent(s):1||secondary prevention:1||sensitivity and specificity:1||sex difference:1||sex differences:1||sexspecific difference:1||side branch:1||side branch ischemia:1||stable ischemic heart disease:1||staged complete revascularization:1||stenosis:1||stress test:1||sub>:1||subtotal occlusion:1||target lesion failure:1||therapeutics:1||tomography:1||tomography, optical coherence:1||tricuspid regurgitation:1||tricuspid valve:1||true bifurcation:1||ultrasonic:1||ultrasound:1||unstable angina:1||variant angina:1||vascular resistance:1||vasospasm:1||vulnerable plaques:1||white blood cell:1||βblocker:1||/sub>:1||βblockers:1||0.0.1:1||12<:1||3D leaflet:1||ACS/NSTEACS:1||Acute cardiac care:1||Acute coronary syndromes:1||Adjunctive pharmacotherapy:1||Aged:1||Amyloidosis:1||Angina pectoris:1||Angiographic scores:1||Angiography:1||Angiotensin II receptor blockers:1||Angiotensin Receptor Blocker:1||Angiotensinconverting enzyme inhibitors:1||Anticoagulation:1||Antiplatelets:1||Area at risk:1||Arrest rhythm:1||Atherosclerotic plaque:1||Atorvastatin:1||Atrial Fibrillation:1||Betablocker:1||Biolimus A9™:1||Biolimuseluting stent:1||Biomarkers:1||Bioresorbable Vascular Scaffold (BVS):1||Bioresorbable vascular scaffold:1||Blood Glucose:1||Blood glucose:1||Borderline anklebrachial index:1||Brain computed tomography:1||Bronchoscopy:1||CTO:1||CTO revascularization:1||CYP2C19 genotype:1||Cardiac Intensive Care Unit:1||Cardiac arrest:1||Cardiac critical care:1||Cardiac diastolic dysfunction:1||Cardiac intensive care unit:1||Cardiac intensivist:1||Cardiac magnetic resonance:1||Cardiogenic shock (CS):1||Cardiology:1||Cardiology General:1||Cardiopulmonary arrest:1||Cardiovascular event:1||Catheter:1||Chest pain:1||Chronic Stable Angina:1||Chronic Total Occlusion:1||Chronic kidney disease:1||Chronic stable angina:1||Clinical outcomes:1||Clinical practice guideline:1||Clinical research:1||Combustible cigarettes:1||Complete revascularization:1||Computed tomography:1||Contrast dye gradien:1||Coronary Disease/Myocardial Infarction:1||Coronary angiography:1||Coronary artery:1||Coronary artery bypass surgery:1||Coronary artery calcification:1||Coronary artery calcium:1||Coronary bifurcation lesion:1||Coronary bifurcation lesions:1||Coronary chronic total occlusion:1||Coronary computed tomography:1||Coronary disease:1||Coronary flow reserve:1||Coronary intervention:1||Coronary microvascular dysfunction:1||Cost:1||Costeffectiveness:1||DAPT:1||Death:1||Distal perfusion catheter:1||Drug Therapy:1||Drug coated balloon:1||Drug eluting stents:1||Drug therapy:1||DrugEluting Stent:1||DrugEluting Stent (DES):1||Drugcoated balloon:1||Drugeluting Stent:1||Drugeluting balloon:1||Dual antiplatelet therapy:1||Early PREdiction of DELIRium:1||Efficacy:1||Electronic cigarettes:1||Ergonovine:1||Everolimuseluting stent:1||Exercise:1||Exercise Test:1||Exercise Treadmill Testing:1||Exercise tests and training:1||Extracorporeal life support:1||Extracorporeal membrane oxygenator:1||Ezetimibe:1||FFR gradient:1||FFRgradient:1||FRAMEAMI:1||Filling pressure:1||Fractional flow reserve, myocardial:1||Fractional myocardial mass:1||Gender:1||Gender difference:1||Generalsurgery:1||Geometry:1||HFAPEFF score:1||HbA1c:1||Heart Failure:1||Heart failure with midrange ejection fraction:1||Heart transplantation:1||Hematoma:1||High bleeding risk:1||Highintensity staffing:1||Highrisk:1||Inhospital cardiac arrest:1||Intermediate coronary artery stenosis:1||Intraaortic balloon pump:1||Intravascular ultrasonography:1||Ischemia:1||Ischemic cardiomyopathy:1||Ischemic postconditioning:1||Ischemic risks:1||Left heart decompression (LHD):1||Left main coronary artery:1||Left main disease:1||Left v:1||Left ventricular systolic dysfunction:1||Limb ischemia:1||MSCT:1||Magnetic resonance im:1||Major cardiovascular event:1||Medical Treatment:1||

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE